The introduction of GLP-1s for weight loss has been a dysfunctional mess, thanks to pharmaceutical companies, insurance plans ...

Jay Bhattacharya’s tenure as NIH director has seen health disparities research swept up in the Trump administration’s attack ...

In early June, a MAGA influencer named Chuck Callesto launched a social media assault on Sen. Bill Cassidy, a Louisiana ...

Science evolves as both controlled clinical research and real-world evidence show us how to use health care technologies to ...

The reshaping of the CDC's vaccine advisory panel has continued, with the apparent barring of reps of medical associations ...

Senators from both parties endorsed a $400 million increase to the budget of the National Institutes of Health on Thursday ...

Eli Lilly’s blockbuster diabetes drug Mounjaro matched the ability of an older treatment to prevent major heart complications ...

Alnylam Pharma raised its revenue outlook as its heart drug sees quick uptake. Biogen, Argenx, Sanofi, and Bristol Myers ...

Senators ignored RFK Jr.'s proposal to create a chronic disease agency called the Administration for a Healthy America.

Facing a range of competitive and government challenges, Moderna announced layoffs Thursday affecting 10% of its workforce.

The Trump administration has proposed a pilot initiative to address controversy over the 340B drug discount program.

It is hard to imagine someone more equipped and more dedicated to vetting treatments than Vinay Prasad,” writes his former ...